Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about SNY Recent news which mentions SNY < Previous 1 2 3 4 5 6 7 8 9 ... 25 26 Next > FDA Approves Regeneron/Sanofi's Blockbuster Dupixent For Smoker's Lung Disease September 27, 2024 Tickers NEWS REGN SNY Tags Market News why it's moving Top Stories From Benzinga Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs September 25, 2024 Tickers AMGN LLY NEWS SNY Tags Analyst Color Market News why it's moving From Benzinga Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market September 25, 2024 Tickers AMGN CGEM NEWS REGN Tags General Briefs Expert Ideas From Benzinga Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff September 25, 2024 Tickers GS GSK HLN JNJ Tags Rumors Media KVUE From Benzinga Sanofi Injects $27M In Neurology Drug Developer Ventyx Biosciences September 23, 2024 Tickers NEWS SNY VTYX Tags SNY News Health Care From Benzinga Sanofi's Sarclisa Secures FDA Approval For First-Line Multiple Myeloma, Marking Its Third US Approval September 23, 2024 Tickers NEWS SNY Tags News Large Cap SNY From Benzinga US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices September 20, 2024 Tickers CI CVS LLY NEWS Tags UNH General Legal From Benzinga Sanofi's Tolebrutinib Delays Disability Progression In Patients With Multiple Sclerosis, Data Shows September 20, 2024 Tickers NEWS SNY Tags General Briefs Biotech From Benzinga Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years September 18, 2024 Tickers NEWS NVS SNY Tags Biotech Health Care Benzinga From Benzinga Should You Buy Novavax Stock After This Regulatory Win? September 13, 2024 Tickers BNTX JNJ MRNA NVAX Tags Market News NVAX MRNA From Motley Fool Sanofi, Regeneron Drug Dupixent Shows Successful Treatment Of Patients With Inflammatory Skin Disease September 11, 2024 Tickers NEWS REGN SNY Tags Top Stories Health Care SNY From Benzinga FDA Battles Backlog of Drug Factory Inspections Since COVID-19 September 06, 2024 Tickers BMRN BMY GSK LLY Tags FDA General Biotech From Benzinga Why Sanofi Stock Was Robustly Healthy Today September 03, 2024 Tickers SNY Tags Recent Press Releases Market News SNY From Motley Fool Sanofi Still Bets On Multiple Sclerosis Med Tolebrutinib Despite The Investigational Drug Fell Short In 2 Of 3 Phase 3 Trials September 03, 2024 Tickers NEWS SNY Tags Briefs Movers Biotech From Benzinga European Stocks Little Moved On Labor Day, German DAX Mark Record Close, Natural Gas Futures Rise: What's Driving Markets Monday? September 02, 2024 Tickers BBSRF BMWYY BX EADSY Tags $BTC TEF ORAN From Benzinga Governments Suing Pharmacy Benefit Managers Over Insulin Prices Have Long Benefited From Their Rebates August 26, 2024 Tickers LLY NEWS NVO SNY Tags Media General Benzinga From Benzinga Wall Street Predicts That This Stock Could Skyrocket by 65%: Time to Buy? August 24, 2024 Tickers NVAX SNY Tags Recent Press Releases NVAX Market News From Motley Fool ARS Pharmaceuticals 'Neffy Uniquely Positioned With Potential To Change Allergy Treatment Paradigm For First Time In 40 years:' Analyst August 20, 2024 Tickers NEWS SNY SPRY Tags Health Care Trading Ideas Top Stories From Benzinga Florida Ruling Upholds GSK's Stance On Once Popular Heart Burn Drug Zantac Not Being Associated With Cancer Risk August 16, 2024 Tickers GSK NEWS PFE SNY Tags Market News SNY Large Cap From Benzinga 3 Biotech Stocks to Buy on the Dip: August 2024 August 15, 2024 Tickers LLY SNY VRTX Tags SNY VRTX LLY From InvestorPlace FDA Approves ARS Pharma's Once Rejected Neffy Nasal Spray Alternative To EpiPen For Emergency Allergy Treatment August 09, 2024 Tickers NEWS SNY SPRY Tags Briefs Movers Biotech From Benzinga COVID-19 Vaccine Maker Novavax Trims Annual Outlook As Q2 Sales Take A Hit August 08, 2024 Tickers NEWS NVAX SNY Tags NVAX General Benzinga From Benzinga Sanofi's Approved Blood Cancer Drug Sarclisa Shows Improved Progression-Free Survival In Patients Eligible For Transplant August 08, 2024 Tickers NEWS SNY Tags Market News Top Stories Health Care From Benzinga Where Will Novavax Be in 5 Years? August 03, 2024 Tickers MRNA NVAX SNY Tags SNY MRNA Market News From Motley Fool Regeneron Pharmaceuticals' Q2 Earnings Exceed Estimates, Driven By Its Top-Selling Eczema And Eye Drugs August 01, 2024 Tickers NEWS REGN SNY Tags General REGN Briefs From Benzinga JPMorgan Just Cut Its Price Target on These 3 Stocks: July 31, 2024 July 31, 2024 Tickers JPM MCD NVAX SNY Tags Market News NVAX ULCC From InvestorPlace JPMorgan Just Issued a Warning on Novavax (NVAX) Stock July 30, 2024 Tickers NVAX SNY Tags Market News NVAX NASDAQ:NVAX,NASDAQ:SNY From InvestorPlace Sanofi (SNY) Q2 2024 Earnings Call Transcript July 25, 2024 Tickers SNY Tags Market News Recent Press Releases SNY From Motley Fool Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday? July 25, 2024 Tickers AAL ABBV AZN BJRI Tags IWM Stories That Matter XLY From Benzinga Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand July 25, 2024 Tickers AZN NEWS REGN SNY Tags Large Cap Guidance News From Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 25 26 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.